Disease Overview：Macular hole（MH）
Macular hole is a full-thickness defect in the central retina—specifically within the fovea of the macula—resulting in progressive loss of central vision, metamorphopsia, and reduced visual acuity. It most commonly arises from vitreomacular traction in older adults, though secondary causes include trauma, high myopia, or cystoid macular edema. Diagnosis relies on spectral-domain optical coherence tomography (SD-OCT), which precisely delineates hole size, stage (Gass classification I–IV), and associated vitreoretinal interface abnormalities. Without intervention, most idiopathic full-thickness holes progress, with spontaneous closure occurring in fewer than 10% of cases. Pars plana vitrectomy with internal limiting membrane (ILM) peeling and intraocular gas tamponade remains the gold-standard surgical treatment; anatomical closure rates exceed 90% in early-stage holes, with significant functional improvement in 70–85% of patients postoperatively.
China offers distinct advantages for macular hole surgery: ophthalmology centers in Beijing, Shanghai, and Guangzhou employ state-of-the-art SD-OCT, intraoperative OCT-guided vitrectomy systems, and micro-incisional instrumentation—matching global technical benchmarks. Leading institutions report >92% anatomical success and consistent visual acuity gains comparable to outcomes published in JAMA Ophthalmology and Ophthalmology journals. Treatment costs are typically 40–60% lower than in the US or Western Europe, without compromising sterility protocols, surgeon credentialing, or postoperative monitoring standards. As a dedicated medical tourism agency, we facilitate seamless access for international patients: verifying surgeon board certification, coordinating appointments at JCI-accredited hospitals, providing itemized, transparent pricing in advance, and managing logistics—including visa support, accommodation, and bilingual clinical liaison services—ensuring continuity of care from consultation through recovery.
Medical Treatment Guide
Treatment Options & Itemized Cost Breakdown: Macular Hole
Non-Surgical / Conservative Management *Indicated only for asymptomatic Stage 1 (impending) holes or patients unfit for surgery.*
- •Baseline OCT + fundus photography: ¥380–¥520 ($53–$73)
- •Annual monitoring (OCT + visual acuity + Amsler grid): ¥260–¥340 ($36–$47) per visit
- •Nutritional supplementation (lutein/zeaxanthin + omega-3): ¥180–¥420/month ($25–$59)
- •*No pharmacologic therapy is evidence-based; corticosteroids, anti-VEGF, or NSAIDs are not indicated and not reimbursed.*
*Standard of care for symptomatic Stage 2–4 macular holes with ≥20/50 vision loss or progressive distortion.*
- •Preoperative workup:
- Systemic clearance (ECG, CBC, renal function): ¥320–¥480 ($45–$67)
- •Core vitrectomy + internal limiting membrane (ILM) peeling + gas tamponade (C3F8 or SF6):
- Tier 2 (tertiary referral center, intraoperative OCT guidance + autologous serum): ¥18,400–¥22,300 ($2,560–$3,100) - Tier 3 (high-volume specialty center, combined cataract surgery if phakic): ¥24,700–¥29,500 ($3,440–$4,100)
- •Postoperative follow-up (3 visits × OCT + VA): ¥1,100–¥1,500 ($153–$209)
- •Recurrent or large (>400 µm) holes: Requires heavy silicone oil tamponade + longer positioning → +¥6,200–¥8,900 ($860–$1,240)
- •Traumatic or myopic macular holes: Combined scleral reinforcement + vitrectomy → ¥31,000–¥37,500 ($4,310–$5,220)
- •Bilateral simultaneous surgery: Discounted bundle at ¥42,000–¥48,800 ($5,850–$6,790)
- •Age <60, good systemic health, Stage 2–3 hole: Prioritize Tier 1 vitrectomy ($1,780–$2,170); highest closure rate (>90%).
- •Age ≥75, cataract present, moderate budget: Tier 3 bundled cataract-vitrectomy ($3,440–$4,100) avoids second surgery.
- •Stage 1, stable vision, comorbidities precluding anesthesia: Conservative monitoring only ($36–$47/visit).
- •Recurrence after prior surgery or high myopia: Refer to tertiary center for silicone oil or scleral reinforcement ($4,310–$6,790).
- •Low-income patients (medical insurance coverage): Tier 1 vitrectomy reimbursed at ~75%; out-of-pocket ≈ $450–$550 after insurance settlement.
Pricing & Service Differences: International / VIP Dept vs. Regular Clinic
International Medical Services (IMS / VIP Departments) at Grade-3A public hospitals and private international clinics operate under self-regulated VIP fee schedules. Fees are higher than standard public clinics (which are subsidized solely for domestic citizens and do not accept overseas insurances). In exchange, international patients receive 6 exclusive medical privileges:
Recommended Hospitals
Explore selected Grade 3A public hospitals in China with rich clinical experience for this condition:
🌴 Recommended Macular hole Medical Vacation Packages
Curated transparent all-inclusive packages combining Macular hole treatment with China top medical destinations:
